News

Devonian Health Group Announces an Exclusive Strategic Alliance with CannTx Life Sciences for the development of Cannabinoid-based Pharmaceutical Drugs.

June 4, 2020

QUEBEC CITY–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical company, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, today announced a Strategic Alliance with CannTx Life Sciences Inc. (“CannTx”), a privately-owned cannabis producer licensed by Health Canada under the Cannabis Act. Under the…

Details

REPEAT/Halo Labs Announces Partnership with Zkittlez™ Providing Award Winning Genetics in Oregon

June 4, 2020

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Company has entered into an exclusive strategic partnership with Terphogz™, LLC (“Zkittlez™”) to develop and commercialize new and unique cannabis genetics in Oregon. Background & Partnership Highlights Terphogz, LLC is a renowned cannabis breeding group…

Details

Halo Labs Announces Partnership with Zkittlez™ Providing Award Winning Genetics in Oregon

June 3, 2020

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Company has entered into an exclusive strategic partnership with Terphogz™, LLC (“Zkittlez™”) to develop and commercialize new and unique cannabis genetics in Oregon. Background & Partnership Highlights Terphogz, LLC is a renowned cannabis breeding group…

Details

POSaBIT Welcomes Mike Apker as Board Director

June 3, 2020

SEATTLE–(BUSINESS WIRE)–POSaBIT is pleased to welcome Mike Apker to its board, where he will serve as Board Director. Mr. Apker brings a lifetime of experience and insight to the POSaBIT team. Mike was founder and CEO of Oberon Financial Technology, an investment management software company which was later acquired by Envestnet, Inc. He recently retired…

Details

SOL Global Announces Update to Normal Course Issuer Bid for Purchase of 5% of Company’s Common Shares

June 3, 2020

TORONTO–(BUSINESS WIRE)–SOL Global Investments Corp. (“SOL Global” or the “Company”) (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) is pleased to announce that it has purchased an aggregate of 551,000 common shares in the capital of the Company (“Common Shares”) during the current purchase cycle pursuant to the Company’s previously announced normal course issuer bid (“NCIB”), which…

Details

SiteOne Landscape Supply to Participate in the William Blair Growth Stock Virtual Conference

June 3, 2020

ROSWELL, Ga.–(BUSINESS WIRE)–SiteOne® Landscape Supply, Inc. (NYSE: SITE), announced today that Doug Black, Chairman and Chief Executive Officer; John Guthrie, Executive Vice President, Chief Financial Officer; and Scott Salmon, Executive Vice President, Strategy and Development, will be participating in William Blair’s 40th Annual Growth Stock Conference on June 9, 2020. Management is scheduled to present…

Details

CB Therapeutics Achieves Another Breakthrough with the Biosynthesis of DMT and Related Tryptamine-based Compounds

June 3, 2020

SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics, Inc. has achieved the first successful biosynthesis of DMT (N,N Dimethyltryptamine) and related tryptamine-based compounds in yeast and has filed a patent on their biosynthetic production process for DMT and related analogs. CB Therapeutics’ development of a DMT production process, and its patent application, closely follows the first biosynthetic production of…

Details

Calyxt’s High Oleic Low Linolenic Soybean Oil Deemed Non-Regulated by USDA

June 3, 2020

ROSEVILLE, Minn.–(BUSINESS WIRE)–Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that its high oleic low linolenic (HOLL) soybean has been deemed a non-regulated article under the “Am I Regulated?” process by Biotechnology Regulatory Services of the Animal and Plant Health Inspection Service (APHIS), an agency of the United States Department of Agriculture (USDA).…

Details

Survey: COVID-19, Market Uncertainty Has Financial Advisers Feeling Bearish for the Next Six Months

June 3, 2020

DENVER–(BUSINESS WIRE)–COVID-19 is wreaking havoc across the country, especially in the financial markets and economy. With trillions of dollars in assets managed by the financial advisory community in the U.S., it’s logical to explore how financial advisers are feeling about the pandemic and their outlook for the economy. According to the 2020 Trends in Investing…

Details

Socati Receives Coveted USDA Certification; Begins Shipping Organic Broad Spectrum and Full Spectrum CBD Ingredient Line Up

June 3, 2020

AUSTIN, Texas–(BUSINESS WIRE)–Socati Corp today announced it has successfully completed the rigorous evaluation process and received official USDA Organic certification for its CBD ingredient line up which can be used in USDA Organic finished products. Significantly, Socati is the only commercial scale producer of USDA Organic certified cannabinoid ingredients with third-party verified non-detectable levels of…

Details

Halo Labs Provides Oregon Sales Update

June 3, 2020

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that retail sales of the Company’s Hush™ branded products have been growing in the state of Oregon. According to BDS Analytics, April 2020 cannabis sales in Oregon’s medical and adult-use dispensaries reached $89.5 million, the state’s best…

Details

FSD Pharma Receives U.S. FDA Approval to Design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis

June 2, 2020

TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has given the company permission to submit an Investigational New Drug Application (IND) for the use of FSD-201 (ultramicronized palmitoylethanolamide, or ultramicronized PEA) to treat COVID-19, the disease caused by…

Details